Katrijn Grupping

Summary

Affiliation: Institute of Tropical Medicine
Country: Belgium

Publications

  1. pmc M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding
    Philippe Selhorst
    Department of Biomedical Sciences, Unit of Virology, Institute of Tropical Medicine, Antwerp, B 2000, Belgium
    Retrovirology 10:12. 2013
  2. pmc MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
    Katrijn Grupping
    Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine of Antwerp, Antwerp, Belgium
    Retrovirology 9:36. 2012
  3. pmc Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
    Nicolas Ruffin
    Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
    J Transl Med 10:144. 2012
  4. pmc Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies
    Tessa Dieltjens
    Department of Microbiology, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium
    Retrovirology 6:113. 2009
  5. pmc Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
    Britta Wahren
    Karolinska Institute, Stockholm, Sweden
    J Transl Med 8:72. 2010

Detail Information

Publications5

  1. pmc M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding
    Philippe Selhorst
    Department of Biomedical Sciences, Unit of Virology, Institute of Tropical Medicine, Antwerp, B 2000, Belgium
    Retrovirology 10:12. 2013
    ..HIV-1 infected cells can establish new infections by crossing the vaginal epithelia and subsequently producing virus in a milieu that avoids the high microbicide concentrations of the vaginal lumen...
  2. pmc MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
    Katrijn Grupping
    Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine of Antwerp, Antwerp, Belgium
    Retrovirology 9:36. 2012
    ..The miniCD4 proteins are a promising class of CD4bs inhibitors. Studying virus evolution under pressure of CD4bs inhibitors could provide insight on the gp120-CD4 interaction and viral entry...
  3. pmc Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
    Nicolas Ruffin
    Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
    J Transl Med 10:144. 2012
    ..These - necessarily overlapping topics - are comprehensively summarised by the Europrise students in the context of other recent exciting data...
  4. pmc Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies
    Tessa Dieltjens
    Department of Microbiology, Unit of Virology, Institute of Tropical Medicine, Antwerp, Belgium
    Retrovirology 6:113. 2009
    ..This study also aimed to use the selected mimotopes as tools to unravel the evolution of the antibody landscape and the viral envelope escape which may provide us with new insights for vaccine design...
  5. pmc Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
    Britta Wahren
    Karolinska Institute, Stockholm, Sweden
    J Transl Med 8:72. 2010
    ..Since training is a major task of the Network, the students of the EUROPRISE PhD program summarized certain presentations and their view of the conference in this paper...